Dexmedetomidine versus haloperidol for sedation of non-intubated patients with hyperactive delirium during the night in a high dependency unit: study protocol for an open-label, parallel-group, randomized controlled trial (DEX-HD trial).

MLA

Minami, Takuma, et al. “Dexmedetomidine versus Haloperidol for Sedation of Non-Intubated Patients with Hyperactive Delirium during the Night in a High Dependency Unit: Study Protocol for an Open-Label, Parallel-Group, Randomized Controlled Trial (DEX-HD Trial).” BMC Anesthesiology, vol. 23, no. 1, June 2023, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s12871-023-02158-1.

APA

Minami, T., Watanabe, H., Kato, T., Ikeda, K., Ueno, K., Matsuyama, A., Maeda, J., Sakai, Y., Harada, H., Kuriyama, A., Yamaji, K., Kitajima, N., Kamei, J., Takatani, Y., Sato, Y., Yamashita, Y., Mizota, T., & Ohtsuru, S. (2023). Dexmedetomidine versus haloperidol for sedation of non-intubated patients with hyperactive delirium during the night in a high dependency unit: study protocol for an open-label, parallel-group, randomized controlled trial (DEX-HD trial). BMC Anesthesiology, 23(1), 1–9. https://doi.org/10.1186/s12871-023-02158-1

Chicago

Minami, Takuma, Hirotoshi Watanabe, Takao Kato, Kaori Ikeda, Kentaro Ueno, Ai Matsuyama, Junya Maeda, et al. 2023. “Dexmedetomidine versus Haloperidol for Sedation of Non-Intubated Patients with Hyperactive Delirium during the Night in a High Dependency Unit: Study Protocol for an Open-Label, Parallel-Group, Randomized Controlled Trial (DEX-HD Trial).” BMC Anesthesiology 23 (1): 1–9. doi:10.1186/s12871-023-02158-1.